top border
top border
Featured Programs

Update on Advanced Breast Cancer Treatment
As novel agents for treating advanced breast cancer continue to evolve, we need to continue to learn how best to use them, how to optimally sequence them, and how to safely combine them.

In this OncLive Peer Exchange, Adam M. Brufsky, MD, leads the expert panel: Sara A. Hurvitz, MD; Joyce A. O'Shaughnessy, MD; Hope S. Rugo, MD; and Christy A. Russell, MD. Practical application of the most recent breast cancer research is discussed.
View Now

Expert Perspectives on Hereditary Testing in Breast Cancer
Adam Brufsky, MD, PhD; Harold Burstein, MD, PhD; and Claudine Isaacs, MD, provide insights on hereditary testing decisions in breast cancer, including the risks and benefits of multi-gene panel use, and communicating the results.
View Now

Featured Video

Hepatocellular Carcinoma (HCC):
Can We Improve Patient Survival?

Hepatocellular Carcinoma (HCC): Can We Improve Patient Survival?
Richard Finn, MD, Laura M. Kulik, MD, and Matthew S. Johnson, MD, FSIR, discuss the evolving systemic treatment paradigm for patients with advanced hepatocellular carcinoma. View now

Gina Columbus

Gina Columbus reports on the latest news in oncology in this week's edition of OncLive News Network.

Publication Bottom Border
Border Publication